کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5945998 1172356 2014 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization
ترجمه فارسی عنوان
اعتبار سنجی ارتباط متابولیت های اسید آمینه اسید زنجیره ای با شدت بیماری های عروق کرونر در بیماران مراجعه کننده به کاتتریزاسیون قلب
کلمات کلیدی
متابولیسم، بیماری عروق کرونر، آمینو اسیدهای زنجیرهای منشعب شده،
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
چکیده انگلیسی


- Validated associations of branched-chain amino acids with coronary artery disease.
- Associations were independent and observed with coronary artery disease extremes.
- Associations remained when adjusted for diabetes and measures of insulin resistance.
- Metabolites may be reporting on novel mechanisms of disease pathogenesis.
- These mechanisms are independent of insulin resistance and diabetes.

ObjectiveTo validate independent associations between branched-chain amino acids (BCAA) and other metabolites with coronary artery disease (CAD).MethodsWe conducted mass-spectrometry-based profiling of 63 metabolites in fasting plasma from 1983 sequential patients undergoing cardiac catheterization. Significant CAD was defined as CADindex ≥ 32 (at least one vessel with ≥95% stenosis; N = 995) and no CAD as CADindex ≤ 23 and no previous cardiac events (N = 610). Individuals (N = 378) with CAD severity between these extremes were excluded. Principal components analysis (PCA) reduced large numbers of correlated metabolites into uncorrelated factors. Association between metabolite factors and significant CAD vs. no CAD was tested using logistic regression; and between metabolite factors and severity of CAD was tested using linear regression.ResultsOf twelve PCA-derived metabolite factors, two were associated with CAD in multivariable models: factor 10, composed of BCAA (adjusted odds ratio, OR, 1.20; 95% CI 1.05-1.35, p = 0.005) and factor 7, composed of short-chain acylcarnitines, which include byproducts of BCAA metabolism (adjusted OR 1.30; 95% CI 1.14-1.48, p = 0.001). After adjustment for glycated albumin (marker of insulin resistance [IR]) both factors 7 (p = 0.0001) and 10 (p = 0.004) remained associated with CAD. Severity of CAD as a continuous variable (including patients with non-obstructive disease) was associated with metabolite factors 2, 3, 6, 7, 8 and 9; only factors 7 and 10 were associated in multivariable models.ConclusionsWe validated the independent association of metabolites involved in BCAA metabolism with CAD extremes. These metabolites may be reporting on novel mechanisms of CAD pathogenesis that are independent of IR and diabetes.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Atherosclerosis - Volume 232, Issue 1, January 2014, Pages 191-196
نویسندگان
, , , , , , , , , , ,